Multiple Manufacturers

APREPITANT

Manufacturer:

Multiple Manufacturers

Aprepitant HCPCS:

J8501

HCPCS Code Descriptor:

Aprepitant, oral, 5 mg

Category:

J Code

Aprepitant NDCs:

13668-0593-86, 68462-0585-76, 00781-2323-68, 13668-0592-86, 68462-0584-76, 00781-2322-68, 00006-3862-03, 13668-0594-87, 00781-4063-36, 68462-0112-33, 13668-0591-82, 68462-0583-85, 00781-2321-51, 00006-0461-02, 00006-3066-03, 13668-0592-84, 00781-2322-46, 68462-0584-58, 13668-0591-81, 68462-0583-40, 00781-2321-06

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Aprepitant:

APREPITANT is an Oncology-Anti-Emetic drug manufactured by Glenmark Pharma and administered via the Oral route of administration. The J Code: J8501 is aligned to the drug APREPITANT.

ACCESS PRICING AND MORE BY REGISTERING

J8501 Added Date:

January 1, 2005

J8501 Effective Date:

January 1, 2019

J8501 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aprepitant billing and coding information.
Our team did not identify a source for Aprepitant patient assistance information. Please reach out to our team if you feel that this is a mistake.
APREPITANT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for APREPITANT. Please check back in a few weeks.